To assess the prevalence of antibodies to hepatitis A virus (anti-HAV) in future travellers, all visitors to the Zurich University Vaccination Center in July/August 1990 were invited to participate in a cross-sectional study. A total of 1126 future travellers were recruited to have a blood sample dr
Evolution of hepatitis a antibodies prevalence in young French military recruits
β Scribed by M. Joussemet; Ph. Bourin; O. Lebot; G. Fabre; R. Deloince
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 240 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0393-2990
No coin nor oath required. For personal study only.
β¦ Synopsis
Hepatitis A antibodies (anti-HAV) were surveyed in 1000 French recruits during 1990. The prevalence of anti-HAV in this group was 21.35%. Compared to a 1985 survey a 9% fall in the anti-HAV prevalence rate was observed. Living in a coastal area, low educational level, stay overseas were the main risk factors, as already noted in 1985.
π SIMILAR VOLUMES
In order to determine the prevalence of antibodies to hepatitis A, C, and E viruses (HAV, HCV, and HEV) in the various ethnic groups and areas of French Guiana, sera (996 for HCV and HEV, 941 for HAV) were tested for antibodies to these viruses using ELISAs. Differences in HAV seroprevalence were fo
Israel, located in a region endemic for hepatitis A virus (HAW, recently absorbed a large population of immigrants who came from the former USSR. To assess the risk of high morbidity in this population a serosurvey of HAV antibodies was undertaken. Serum samples were collected from 965 new immigrant
## Abstract The objective of this study was to investigate the prevalence of hepatitis A antibodies (antiβHAV) in schoolchildren in Catalonia and to compare it with the rates found in previous studies. Sera from a representative sample of 1,342 children aged between 6 and 15 years, recruited in 200
## Abstract Several studies had been carried out on antiβhepatitis C virus (HCV) prevalence in populations with blood exposure risks and in blood donors. New tests are now available which allow the inβ vestigation to extend to other parameters such as antibody type and HCVβRNA. In this study the p